Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Zsuzsanna Veres is active.

Publication


Featured researches published by Zsuzsanna Veres.


Acta Veterinaria Hungarica | 2013

Epigenetic effects of dietary butyrate on hepatic histone acetylation and enzymes of biotransformation in chicken

Gábor Mátis; Zsuzsanna Neogrády; György Csikó; Péter Gálfi; Hedvig Fébel; Katalin Jemnitz; Zsuzsanna Veres; Anna Kulcsár; Ákos Kenéz; Korinna Huber

The aim of the study was to investigate the in vivo epigenetic influences of dietary butyrate supplementation on the acetylation state of core histones and the activity of drug-metabolising microsomal cytochrome P450 (CYP) enzymes in the liver of broiler chickens in the starter period. One-day-old Ross 308 broilers were fed a starter diet without or with sodium butyrate (1.5 g/kg feed) for 21 days. After slaughtering, nucleus and microsome fractions were isolated from the exsanguinated liver by multi-step differential centrifugation. Histone acetylation level was detected from hepatocyte nuclei by Western blotting, while microsomal CYP activity was examined by specific enzyme assays. Hyperacetylation of hepatic histone H2A at lysine 5 was observed after butyrate supplementation, providing modifications in the epigenetic regulation of cell function. No significant changes could be found in the acetylation state of the other core histones at the acetylation sites examined. Furthermore, butyrate did not cause any changes in the drugmetabolising activity of hepatic microsomal CYP2H and CYP3A37 enzymes, which are mainly involved in the biotransformation of most xenobiotics in chicken. These data indicate that supplementation of the diet with butyrate probably does not have any pharmacokinetic interactions with simultaneously applied xenobiotics.


Journal of Colloid and Interface Science | 2017

Direct immobilization of manganese chelates on silica nanospheres for MRI applications

Marcell Pálmai; Adrienn Pethő; Lívia Nagy; Szilvia Klébert; Zoltán May; Judith Mihály; András Wacha; Katalin Jemnitz; Zsuzsanna Veres; Ildiko Horvath; Krisztián Szigeti; Domokos Máthé; Zoltán Varga

The development of tissue specific magnetic resonance imaging (MRI) contrast agents (CAs) is very desirable to achieve high contrast ratio combined with excellent anatomical details. To this end, we introduce a highly effective manganese(II) containing silica material, with the aim to shorten the longitudinal (T1) relaxation time. The microporous silica nanospheres (MSNSs) with enlarged porosity and specific surface area were prepared by a surfactant assisted aqueous method. Subsequently, the surface silanol groups were amino-functionalized, reacted with diethylenetriaminepentaacetic (DTPA) dianhydride and finally deposited with Mn2+. After comprehensive characterization, the MRI properties of functionalized MSNSs were investigated. The resulting nanospheres demonstrated substantial contrast enhancement during the in vitro MRI investigations, which was also evidenced by significant contrast enhancement on T1-weighted MR images in vivo. Moreover, in vitro cytotoxicity assay of functionalized MSNSs on hepatocyte mono- and hepatocyte-Kuppfer cell co-cultures showed no significant decrease in cell viability. Our findings confirmed our hypothesis, that Mn2+-chelating MSNSs are appropriate candidates for liver-specific T1-weighted MRI CAs with high relaxivities (r1=7.18mM-1s-1).


Journal of Bioactive and Compatible Polymers | 1990

Contribution to physiological properties of poly(N-vinylpyrrolidone-alt-maleic acid), toxicity and hemagglutination tests

Mária Azori; Zsuzsanna Veres; Géza Dénes; F. Tüdös

Acute toxicity of the copolymer of poly(N-vinylpyrrolidone-alt-maleic acid) is examined by two routes of parenteral administration. The effect of prolonged daily treatment of animals, the results of hemagglutination tests of the original, and the modified copolymer as polymer drug models are discussed.


Scientific Reports | 2017

Functional shift with maintained regenerative potential following portal vein ligation

Tibor Kovács; Domokos Máthé; András Fülöp; Katalin Jemnitz; Attila Bátai-Konczos; Zsuzsanna Veres; György Török; Dániel S. Veres; Ildiko Horvath; Krisztián Szigeti; László Homolya; Attila Szijártó

Selective portal vein ligation (PVL) allows the two-stage surgical resection of primarily unresectable liver tumours by generating the atrophy and hypertrophy of portally ligated (LL) and non-ligated lobes (NLL), respectively. To evaluate critically important underlying functional alterations, present study characterised in vitro and vivo liver function in male Wistar rats (n = 106; 210–250 g) before, and 24/48/72/168/336 h after PVL. Lobe weights and volumes by magnetic resonance imaging confirmed the atrophy-hypertrophy complex. Proper expression and localization of key liver transporters (Ntcp, Bsep) and tight junction protein ZO-1 in isolated hepatocytes demonstrated constantly present viable and well-polarised cells in both lobes. In vitro taurocholate and bilirubin transport, as well as in vivo immunohistochemical Ntcp and Mrp2 expressions were bilaterally temporarily diminished, whereas LL and NLL structural acinar changes were divergent. In vivo bile and bilirubin-glucuronide excretion mirrored macroscopic changes, whereas serum bilirubin levels remained unaffected. In vivo functional imaging (indocyanine-green clearance test; 99mTc-mebrofenin hepatobiliary scintigraphy; confocal laser endomicroscopy) indicated transitionally reduced global liver uptake and -excretion. While LL functional involution was permanent, NLL uptake and excretory functions recovered excessively. Following PVL, functioning cells remain even in LL. Despite extensive bilateral morpho-functional changes, NLL functional increment restores temporary declined transport functions, emphasising liver functional assessment.


Drugs Under Experimental and Clinical Research | 1987

Biological activity of the potent uridine phosphorylase inhibitor 5-ethyl-2,2'-anhydrouridine.

Zsuzsanna Veres; Istvan Szinai; Anna Szabolcs; K. Ujszaszy; Géza Dénes


Macromolecular Chemistry and Physics | 1986

Polymeric prodrugs, 3. Synthesis, elimination, and whole‐body distribution of 14C‐labelled drug carrier

Mária Azori; Istvan Szinai; Zsuzsanna Veres; János Pató; L. Ötvös; Ferenc Tüdős


Archive | 2013

Investigation of the effect of butyrate supplementation of the diet on hepatic cytochrome P450 enzymes in rats

Gábor Mátis; György Csikó; Katalin Jemnitz; Zsuzsanna Veres; Hedvig Fébel; Anna Kulcsár; Janka Petrilla; Zsuzsanna Neogrády


Archive | 2013

EPIGENETIC EFFECTS OF DIETARY BUTYRATEON HEPATIC HISTONE ACETYLATION AND ENZYMESOF BIOTRANSFORMATION IN CHICKEN

Gábor Mátis; Zsuzsanna Neogrády; György Csikó; Péter Gálfi; Hedvig Fébel; Katalin Jemnitz; Zsuzsanna Veres; Anna Kulcsár; Ákos Kenéz; Korinna Huber


Archive | 2007

A humán genotoxicitás kutatásának és kimutatásának korszerűsítése = Study of human genotoxicity: An Update and practical considerations

Zsuzsanna Veres; Márta Csík; Katalin Jemnitz; György Lengyel; Géza Török


Acta pharmaceutica Hungarica | 1998

HUMAN GYOGYSZERMETABOLIZALO ENZIMEK. I. OXIDACIOS ENZIMEK

L. Vereczkey; Katalin Monostory; Zsuzsanna Veres

Collaboration


Dive into the Zsuzsanna Veres's collaboration.

Top Co-Authors

Avatar

Katalin Jemnitz

Hungarian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Anna Kulcsár

Szent István University

View shared research outputs
Top Co-Authors

Avatar

György Csikó

Szent István University

View shared research outputs
Top Co-Authors

Avatar

Gábor Mátis

Szent István University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hedvig Fébel

National Agricultural Research Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Géza Dénes

Hungarian Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Istvan Szinai

Hungarian Academy of Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge